Medicine and Dentistry
Liposome
100%
down Regulation
100%
Nanobody
100%
Epidermal Growth Factor Receptor
100%
Receptor
72%
Internalization
27%
Receptor down Regulation
27%
In Vitro
18%
Cell Surface
18%
Neoplasm
9%
Cancer Therapy
9%
Lysosome
9%
Ligand
9%
Monoclonal Antibody
9%
Polyethylene Glycol
9%
Tumor Cell
9%
Epitope
9%
Cell Proliferation
9%
Ligand Binding
9%
Cetuximab
9%
Anti-Epidermal Growth Factor Receptor
9%
Receptor Antagonist
9%
Single Chain Fragment Variable Antibody
9%
Immunoglobulin Fragment
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Nanobody
100%
Epidermal Growth Factor Receptor
100%
Receptor
90%
Neoplasm
27%
Ligand
18%
Cell Proliferation
9%
Mouse
9%
Antigen
9%
Monoclonal Antibody
9%
Epitope
9%
Cetuximab
9%
Receptor Antagonist
9%
Immunoglobulin Fragment
9%
Single Chain Fragment Variable Antibody
9%
Immunology and Microbiology
down Regulation
100%
Single-Domain Antibody
100%
Epidermal Growth Factor
100%
Degradation
27%
Internalization
27%
Receptor down Regulation
27%
Cell Surface
18%
Mouse
9%
Binding Antibody
9%
Epitope
9%
Cell Proliferation
9%
Tumor Cell
9%
Lysosome
9%
Ligand Binding
9%
Cetuximab
9%
Immunoglobulin Fragment
9%
Single-Chain Variable Fragment
9%
Monoclonal Antibodies
9%